Stonehouse Jon P bought BCRX
August 31, 2026 · Form 4 insider transaction
Stonehouse Jon P bought 644 shares of BioCryst Pharmaceuticals, Inc. at $9.70 per share, a transaction worth $6.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
644
Price
$9.70
Total value
$6.2K
InsiderStonehouse Jon P
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 31, 2026
Filing dateSeptember 2, 2026
Shares owned after1,340,419
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500.